Danone launches new science-based probiotic supplement to support breastfeeding experiences

• Mastitis, which affects approximately 1 out of 4 breastfeeding mothers¹, is considered one of the leading causes of an early and unwanted end to breastfeeding²
  
• Danone’s new probiotic supplement, Almimama, now launched in Spain, can support breastfeeding by helping to reduce the incidence of mastitis, according to findings from a clinical study
  
• Despite the well-established benefits of breastfeeding for the health of both mother and baby, only 48% of babies under 6 months of age are exclusively breastfed³
   

Danone has used its expertise in breastmilk research and breastfeeding to develop Almimama, a probiotic supplement that can help reduce the incidence of mastitis. Affecting approximately one in four mothers¹, mastitis (inflammation in the breast) causes flu-like symptoms and breast pain, as well as skin rashes, fever and breast engorgement.

Breastmilk is widely recognized as nature’s most powerful nutrition and tailormade for a baby’s needs, providing many short- and long-term benefits for both babies and mothers. Despite these benefits, only 48% of babies under six months of age are exclusively breastfed³.

Research has shown complications like mastitis are one of the key barriers to continue breastfeeding⁴. Research has shown probiotic supplementation during late pregnancy and in the early stages of breastfeeding reduces the incidence of mastitis^2,5. Probiotics or ‘’good bacteria’’ are live microorganisms that, when administered in adequate amounts, bring a health benefit to the people consuming them. Almimama is the only synbiotic supplement for pregnant or lactating mothers that combines the probiotic strain L. salivarius PS2 with fructo-oligosaccharides (FOS).